Cabaletta Bio, Inc. (CABA)

CIK 0001759138 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-14) · 99.1  |  8-K (2026-05-04) · 99.1 · 99.2
Latest FY-2025 8-K (2026-03-23) · 99.1 · 99.2
Q3-2025 8-K (2025-11-10) · 99.1
Q2-2025 8-K (2025-08-07) · 99.1
Q1-2025 8-K (2025-05-15) · 99.1
FY-2024 8-K (2025-03-31) · 99.1  |  8-K (2025-01-13) · 99.1 · 99.2
Q3-2024 8-K (2024-11-14) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1 · 99.2
Q1-2024 8-K (2024-05-15) · 99.1 · 99.2
FY-2023 8-K (2024-03-21) · 99.1  |  8-K (2024-01-08) · 99.1 · 99.2
Q3-2023 8-K (2023-11-09) · 99.1 · 99.2
Q2-2023 8-K (2023-08-10) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Balance Sheets
Consolidated Balance Sheets
Balance Sheets (P)
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Statements of Operations and Comprehensive Loss
Consolidated Statements of Stockholders' Equity
Statements of Stockholders' Equity
Consolidated Statements of Stockholders' Equity (P)
Statements of Stockholders' Equity (P)
Consolidated Statements of Cash Flows
Statements of Cash Flows
Notes
401(k) Savings Plan
—
Accrued and Other Current Liabilities
Award Timing Disclosure
—
Basis of Presentation
Collaborations, Licensing Agreements and Other Agreements
Commitments and Contingencies
Common Stock
Cybersecurity Risk Management, Strategy, and Governance
—
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
Net Loss Per Share
Pay Vs Performance Disclosure
Property, Plant and Equipment
—
Segment Information
Summary of Significant Accounting Policies